Core Points - The stock price of Gongdong Medical (605369) increased by 2.37% this week, closing at 19.44 yuan as of October 10, 2025, with a market cap of 4.286 billion yuan [1] - The company revised its articles of association, confirming its status as a permanent company with a registered capital of 220,492,949 yuan [2] Company Announcements - Gongdong Medical's articles of association state that it is a permanent limited company with a registered capital of 220,492,949 yuan, focusing on the production and operation of Class III medical devices [2] - The company has established a shareholder meeting, board of directors, and supervisory board, outlining the rights and obligations of shareholders, directors, and senior management [2] - Directors and senior management are prohibited from insider trading, and any short-term trading profits by shareholders holding over 5% of shares must be returned to the company [2] - The profit distribution policy emphasizes cash dividends, with a minimum of 10% of distributable profits to be distributed annually [2] - Major transactions and external guarantees require approval from the board or shareholders' meeting [2] - The company is allowed to repurchase shares for employee incentives or capital reduction, with a maximum repurchase limit of 10% of the total issued shares [2] - The articles also regulate the procedures for shareholder meetings, board meetings, mergers, divisions, dissolution, and liquidation [2]
每周股票复盘:拱东医疗(605369)修订章程强化治理